...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: NR on phase 1 Kidney Trial

I especially liek the qoute from DM  "It was shocking and highly encouraging to see the direct comparison of the protein data ranked by magnitude of effect in the two groups. For the first time, epigenetic and BET inhibition clinical data has been shown to differentially affect genes and proteins between advanced chronic kidney disease (CKD) patients and normal subjects," stated Donald McCaffrey, President and CEO.

 

First time i have ever seen a quote as "shocking ", is this a new approach or is it really shocking???

3
Jan 23, 2017 12:37PM
2
Jan 23, 2017 02:04PM
4
Jan 23, 2017 03:49PM
Share
New Message
Please login to post a reply